NasdaqGM - Nasdaq Real Time Price USD

Alvotech (ALVO)

10.48
-0.02
(-0.19%)
As of 2:36:45 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
585,595
489,682
91,434
83,029
36,772
Cost of Revenue
230,799
185,309
160,856
64,095
0
Gross Profit
354,796
304,373
-69,422
18,934
36,772
Operating Expense
226,151
234,729
285,438
365,376
272,228
Operating Income
128,645
69,644
-354,860
-346,442
-235,456
Net Non Operating Interest Income Expense
121,065
-152,984
-130,001
-90,526
-114,538
Other Income Expense
-148,685
-134,223
-166,188
-114,679
200,796
Pretax Income
101,025
-217,563
-651,049
-551,647
-149,198
Tax Provision
4,480
14,301
-99,318
-38,067
-47,694
Net Income Common Stockholders
96,545
-231,864
-551,731
-513,580
-101,504
Diluted NI Available to Com Stockholders
96,545
-231,864
-551,731
-513,580
-101,504
Basic EPS
0.41
-0.87
-2.43
-2.60
-0.92
Diluted EPS
0.37
-0.87
-2.43
-2.60
-0.92
Basic Average Shares
276,791.53
267,924.57
227,256.47
197,530.77
110,673.31
Diluted Average Shares
284,826.70
267,924.57
227,256.47
197,530.77
243,649.51
Total Operating Income as Reported
128,645
69,644
-354,860
-346,442
-235,456
Total Expenses
456,950
420,038
446,294
429,471
272,228
Net Income from Continuing & Discontinued Operation
96,545
-231,864
-551,731
-513,580
-101,504
Normalized Income
238,636.50
-125,827.83
-416,956.91
-409,225.14
-239,689.52
Interest Income
130,142
4,617
4,823
912
19
Interest Expense
5,463
153,987
133,167
77,474
112,971
Net Interest Income
121,065
-152,984
-130,001
-90,526
-114,538
EBIT
106,488
-63,576
-517,882
-474,173
-36,227
EBITDA
138,858
-32,275
-493,672
-453,764
-18,031
Reconciled Cost of Revenue
230,799
158,267
140,167
47,040
0
Reconciled Depreciation
32,370
31,301
24,210
20,409
18,196
Net Income from Continuing Operation Net Minority Interest
96,545
-231,864
-551,731
-513,580
-101,504
Total Unusual Items Excluding Goodwill
-148,685
-134,223
-159,035
-112,089
203,214
Total Unusual Items
-148,685
-134,223
-159,035
-112,089
203,214
Normalized EBITDA
287,543
101,948
-334,637
-341,675
-221,245
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-6,593.50
-28,186.83
-24,260.91
-7,734.14
65,028.48
12/31/2021 - 6/16/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ELAN Elanco Animal Health Incorporated
12.90
+0.12%
 
RGC Regencell Bioscience Holdings Limited
405.69
+18.28%
 
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.2220
-4.89%
 
EBS Emergent BioSolutions Inc.
5.46
-3.28%
 
TEVA Teva Pharmaceutical Industries Limited
17.00
+0.62%
 
IXHL Incannex Healthcare Inc.
0.3181
-54.74%
 
BCRX BioCryst Pharmaceuticals, Inc.
10.33
+4.87%
 
PRFX PainReform Ltd.
1.9100
-2.55%
 
AYTU Aytu BioPharma, Inc.
2.2050
+63.10%
 
VTRS Viatris Inc.
8.79
+4.33%